Alkermes (ALKS) EBIT Margin Growth (3y) (2013 - 2026)
Alkermes (ALKS) EBIT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,673.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -37.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,395.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,442.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1,299.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 5,091.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5,193.00 |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | -847.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -847.00 |
| Dec 31, 2025 | -2,283.00 |
| Sep 30, 2025 | 191,763.00 |
| Jun 30, 2025 | 110,058.00 |
| Mar 31, 2025 | 1,404.00 |
| Dec 31, 2024 | -205.00 |
| Sep 30, 2024 | 3,439.00 |
| Jun 30, 2024 | 2,607.00 |
| Mar 31, 2024 | 1,890.00 |
| Dec 31, 2023 | 2,545.00 |
| Sep 30, 2023 | 2,744.00 |
| Jun 30, 2023 | 5,916.00 |
| Mar 31, 2023 | 1,136.00 |
| Dec 31, 2022 | 23,662.00 |
| Sep 30, 2022 | -187,402.00 |
| Jun 30, 2022 | -106,395.00 |
| Mar 31, 2022 | 2,452.00 |
| Dec 31, 2021 | 3,855.00 |
| Sep 30, 2021 | 826.00 |
| Jun 30, 2021 | 149.00 |